Solid tumor
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age 18 years or older 2.Diagnosed with a solid tumor 3.Currently receiving or scheduled to initiate treatment with a regimen including cytotoxic anticancer agents or Antibody-Drug Conjugate 4.Provided written informed consent
Exclusion criteria
Exclusion criteria: 1.Cognitive impairment that precludes completion of the PRO questionnaire 2.Psychiatric or psychological conditions that preclude completion of the PRO questionnaire 3.Native language is not Japanese 4.Already received the seasonal influenza vaccine for the current season 5.Unable to complete ePRO using a Bring Your Own Device (BYOD)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To clarify patients' roles in decision-making regarding influenza vaccination (Active, Collaborative, Passive) and to examine their association with vaccination readiness. | — |
Secondary
| Measure | Time frame |
|---|---|
| Estimation of the proportions of actual and preferred roles (Active, Collaborative, Passive) based on the Control Preference Scale (CPS) at the time of decision-making regarding vaccination. Estimation of the agreement proportion and agreement coefficient between actual and preferred CPS roles (Active, Collaborative, Passive) at baseline. Estimation of the total score and domain-specific scores of the 7C scale. Estimation of the proportion of patients with high vaccination readiness, defined as a total 7C score of 4.02 or higher. Comparison of DRS scores across groups defined by CPS roles and concordance/discordance of roles at baseline. Comparison of each 7C domain score across groups defined by CPS roles and concordance/discordance of roles at baseline. | — |
Countries
Japan
Contacts
Tokyo Medical University Hospital Department of Pharmacy